PIVOT is Patient-centric Innovative Vision hOme Testing.
The STSI mobile application for The Pivot Study facilitates the identification and enrollment process of appropriate individual patients and healthcare professionals in a clinical trial. The PIVOT research study focuses on use of another mobile medical application (called the myVisionTrack®, or mVT™, application) which is used to monitor a patient’s vision at home. You or a loved one may have already been (or could possibly be) selected as a possible participant in this study because you are being treated for diabetic macular edema (DME) or neovascular age related macular degeneration (nAMD) and are receiving injections of Lucentis® from your ophthalmologist.
The Pivot Study will determine whether patients can use the mVT™ mobile medical application on a smart phone (Apple iPhone®) or digital tablet (Apple iPad® or Apple iPad Mini®) to monitor their vision at home. The goal of the study is to determine the feasibility of involving patients in monitoring their visual function at home using the mVT™ application. The study will also evaluate how comfortable patients are using the mVT™ application and will assess your ophthalmologist’s thoughts on home vision monitoring using this application.
The Scripps Translational Science Institute (STSI) aims to replace the status quo of one-size-fits-all-medicine with individualized health care that is based on the known genetic factors influencing health and disease and that leverages advances in digital (and mobile) technology for realtime health monitoring.
To find out if you or a loved one qualifies for this study, please visit www.ThePivotStudy.com.
Please note: This app employs GPS to help ascertain patient-doctor collocation while using certain features of the app. Users are advised that continued use of GPS running in the background can dramatically decrease battery life.